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Available online 7 September 2016The increasing availability of emerging non-combusted tobacco products (snus, dissolvables, and electronic nic-
otine delivery systems or ENDS)may have implications for pregnantwomen andwomen of reproductive age.We
conducted 15 focus groups to explore howwomen perceive emerging non-combusted tobacco products and nic-
otine replacement therapy (NRT) in general, and during pregnancy. Sessionswere held in 2013 in four U.S. cities.
Participants were 18–40 years old and were pregnant smokers, pregnant quitters, or smokers planning a preg-
nancy. Responses were coded and analyzed to identify key themes using NVivo 10.0 qualitative software (QSR).
Several themes emerged from focus groups. Participants generally found snus unappealing, but viewed dissolv-
ables as a discreet and stigma-free way to use tobacco during pregnancy. Participants perceived NRT as ineffec-
tive and having undesired side effects. ENDS were thought to offer advantages over cigarettes, including use in
smoke-free areas, lower cost, appealing ﬂavors, and fewer health effects, and were seen by some as a potential
quit aid. Some participants, however, worried that the lack of natural stopping point could lead to excessive
use. Many participants felt that the use of any tobacco or NRT product is harmful during pregnancy.
Women seeking to reduce health risks or stigma related to smoking during pregnancy may perceive advantages
of using some emerging products over cigarettes. These ﬁndings can inform future public health efforts to reduce
risks associated with tobacco product use among women of reproductive age.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Smoking during pregnancy remains a major preventable cause of
maternal and infant morbidity and mortality and is causally associated
with ectopic pregnancy, preterm delivery, placental abruption, placenta
previa, and perinatal mortality (U.S. Department of Health and Human
Services, 2014). An estimated 10% of pregnant women in the U.S.
smoke cigarettes, exposing over 400,000 fetuses annually to nicotine
and other toxicants (U.S. Department of Health and Human Services,
2014; Tong et al., 2013). Nicotine is a reproductive toxicant (State of
California Environmental Protection Agency, 2016), and has adverse ef-
fects on pregnancy outcomes and fetal brain and lung development
(U.S. Department of Health and Human Services, 2014). Becausems; NRT, nicotine replacement
are those of the authors and do
.
F-79Atlanta, GA30341, United
ss article under the CC BY-NC-ND licenicotine use during pregnancy in any form has health risks, nicotine re-
placement therapy (NRT) should only be considered if behavioral ap-
proaches fail and after discussion between a woman and her health
care provider regarding the potential risks and beneﬁts (Food and
Drug Administration, 2016; American College of Obstetricians and
Gynecologists, 2011).
The tobacco landscape has changed dramatically in recent years
with the introduction and promotion of non-combusted products such
as snus (moist snuff packaged in pouches that resemble small tea
bags), dissolvable tobacco products (ﬁnely milled tobacco pressed into
tablets, strips, or sticks), and electronic nicotine delivery systems
(ENDS) (devices that utilize a heating element that vaporizes a liquid
solution such as propylene glycol combined with nicotine and ﬂavor-
ings) including electronic cigarettes. Public health concerns related to
the increased availability of non-combusted products include that
they might appeal to individuals who otherwise would not have used
tobacco products or to smokerswho otherwisewould have quit tobacco
products entirely (U.S. Department of Health and Human Services,
2014). Furthermore, messages implying that non-combusted products
are safe (often without discussing the health risks) appear frequentlynse (http://creativecommons.org/licenses/by-nc-nd/4.0/).
482 L.J. England et al. / Preventive Medicine Reports 4 (2016) 481–485in the media (Electronic Cigarette–ecigarette: Featured on The Doctors
TV Show, 2010; International Vape Group, 2016; Vapour Art, 2016; RJ
Reynolds, 2016; Daily Mail, 2013; British American Tobacco, 2016)
and could inﬂuence consumers' tobacco use behaviors.
Pregnant smokers are generally aware that smoking causes fetal
harm and are motivated to quit smoking or reduce their exposure to
harmful chemicals (Tong et al., 2008, 2013; Polen et al., 2105).
Therefore, pregnant women and those planning a pregnancy may be
particularly susceptible to messages regarding the health effects non-
combusted products. Limited data suggest this is the case; in a 2015 sur-
vey of a convenience sample of pregnantwomen, 43% of the entire sam-
ple reported that electronic cigarettes are less harmful to a fetus than
conventional cigarettes and 74% of ever-electronic cigarette users re-
ported that reducing harmwas a reason for past use (Mark et al., 2015).
In the current study, we assessed women's perceptions toward
emerging non-combusted tobacco and NRT products. Speciﬁcally, we
conducted qualitative research among pregnant smokers, pregnant
quitters, and female smokers planning a pregnancy to address two
research questions: 1) How do women perceive emerging non-
combusted tobacco products and NRT use in general and during
pregnancy? and 2) How do women perceive the health risks associated
with these products?
2. Methods
The authors developed a screening questionnaire and facilitator's
guide and tested it in two pilot focus groups conducted in Atlanta, Geor-
gia. Screening questionnaires were designed to collect basic demo-
graphic information and to ensure participants met inclusion criteria
(age 18–40 years, currently smoking and pregnant or planning to be-
come pregnant in the next year; pregnant and had quit smoking and
remained abstinent for at least 30 days). Topics in the facilitator's
guide included tobacco use history, familiarity with emerging tobacco
products (snus, dissolvables, electronic cigarettes or ENDS) and NRT,
general perceptions of emerging products and NRT, perceptions of
emerging products and NRT when used during pregnancy, and health
effects of emerging products and NRT in general and during pregnancy.
Pilot study ﬁndings were used to reﬁne the two instruments. Fifteen
focus groups were conducted between September and November
2013 in Memphis, Tennessee; Philadelphia, Pennsylvania; Oklahoma
City, Oklahoma; and Billings, Montana (Table 1). City selection was
based on the prevalence of smoking among pregnant women. Two of
the 15 groups were conducted in Spanish; the remaining groups were
conducted in English. Committees for the Protection of Human Subjects
fromCDC andRTI International reviewed and approved the study proto-
col. Prior to participating in the focus group discussion, each participant
signed an informed consent form agreeing to participate in the study
and to have discussions observed and audio and video recorded.
Professional market research facilities recruited participants using
their proprietary databases. All respondents were screened for eligibili-
ty by telephone. Because we relied on a convenience sample, data were
not collected for nonparticipants. A total of 102 women were recruited,
with an average of 7 women per group (groups ranged from 5 to 9 par-
ticipants; one informant interview was conducted with a single partici-
pant). Except for the two groups conducted with Spanish-speaking
Hispanic women, groups were not segmented by race or ethnicity. AnTable 1
Location and segmentation of focus groups, U.S., 2013.
Billings, MT Oklahoma City, OK
Pregnant Planning Pregnant Planning
Smokers children Smokers children Smokers no childrena Smokers children
Smokers no children Quitters children Smokers no childrena
Quitters no children Quitters children
a Spanish speaking.experienced female moderator conducted the focus groups, which
were held at the market research facilities and lasted approximately
90 min. Study staff observed the groups via the video stream or from
the facilities' observation room. Women were shown speciﬁc products
at the time the product category was introduced into the discussion
(Table 2). Products were introduced in rotating order to minimize
order bias. At the conclusion of the groups, participants were given a
brochure describing the health effects of smoking during pregnancy
and resources for quitting or staying quit (including the National
Quitline number 1-800-QUIT-NOW and online resources), and mone-
tary compensation of $75.
Researchers followed established procedures to analyze data
(Krueger and Casey, 2000; Southwell et al., 2005). Audio tapes were
transcribed and uploaded into a qualitative software program (QSR
NVivo 10.0). Data were segmented into three groups: pregnant
smokers, pregnant quitters, and smokers planning a pregnancy. The re-
search team coded the responses according to a set of codes developed a
priori that represented key constructs, including general perceptions re-
lated to non-combusted products and NRT and perceptions of health
risks associated with non-combusted products and NRT. Emergent
codes were developed for responses that did not ﬁt with a priori
codes. The research team identiﬁed key themes. To determine inter-
coder reliability, three analysts independently coded segments from a
transcript. We calculated Krippendorff's alpha (Hayes and
Krippendorff, 2007) for each category and found adequate agreement
with alpha exceeding 0.70 for all categories. The research team then or-
ganized the key themes around the two research questions. The goal of
this formative study was to identify the range of perceptions surround-
ing the use of emerging tobacco products and NRT, and not to quantify
the frequency of responses or consensus of opinion. Throughout the re-
port, quotes from participants are used to illustrate the themes.3. Results
Participant characteristics are described in Table 3. Forty-two per-
cent of participants were smokers planning to become pregnant, 31%
were pregnant smokers, and 26% were pregnant quitters. Nearly half
(49%) were non-Hispanic white, 24% were non-Hispanic African Amer-
ican, and 22%were Hispanic. Almost two thirds (61%) had at least some
college education. One third (33%) had tried or were currently using
products other than traditional cigarettes, including snus, chewing to-
bacco, hookah, and electronic cigarettes. Demographic characteristics
varied by pregnancy/smoking status (Table 3).3.1. Prior experiences with tobacco and NRT
Most current smokers had tried in the past to quit; methods includ-
ed NRT, electronic cigarettes, and “cold turkey.” Women often cited
stress as the reason for subsequent relapse. Motivations for quitting
during the current pregnancy included a desire to protect the health
of their babies and a decreased desire to smoke, often related to nausea.
Many current smokers reported that they had tried to quit in prepa-
ration for or after becoming pregnant, or had cut down on the number
of cigarettes smoked per day.Memphis, TN Philadelphia, PA
Pregnant Planning Pregnant Planning
Smokers no children Smokers children Quitters children Smokers no children
Quitters children Smokers no children
Table 2
Products viewed by study participants of focus groups, U.S. 2013.
Product Brand
Electronic cigarettes/ENDSa Blu
Njoy
E-Go-TTank
Snus Camel
Marlboro
Dissolvables Camel orbs
Camel sticks
Camel strips
Nicotine gum Nicorette
NICOrelief
Nicotine patch Nicoderm CQ
Equate
Nicotine lozenges Commit
Generic brand
a Electronic nicotine delivery systems.
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3.2.1. General, not speciﬁc to pregnancy
3.2.1.1. Product familiarity.Many participants were unfamiliarwith snus.
Those familiar with snus often associated it with chewing tobacco and
spitting, and felt the product was intended for people who already
used chewing tobacco, especially men. Others associated it with sports
or the workplace (where smoking is prohibited). Very few participants
were familiar with dissolvables, and none had tried them. In contrast,
many participants were familiar with ENDS and NRT, throughTable 3
Characteristics of focus group participants, pregnant smokers, pregnant quitters, and non-
pregnant smokers planning a pregnancy, U.S. 2013 (N= 102).
Characteristic Pregnant
smokers
(n= 32)
Pregnant
quitters
(n= 27)
Smokers planning
to become pregnant
(n= 43)
Location
Billings, MT 53% (17) 30% (8) 19% (8)
Memphis, TN 22% (7) 19% (5) 28% (12)
Oklahoma City, OK 25% (8) 48% (13) 35% (15)
Philadelphia, PA 0% (0) 4% (1) 19% (8)
Have children at home
28% (9) 67% (18) 49% (21)
Days smoke per week
1 to 2 6% (2) NA 2% (1)
3 to 4 13% (4) NA 19% (8)
5 to 6 16% (5) NA 12% (5)
7 66% (21) NA 56% (24)
Missing 0 0 12% (5)
Use other tobacco productsa
28% (9) 19% (5) 47% (20)
Age
18–23 41% (13) 7% (2) 14% (6)
24–29 44% (14) 22% (6) 37% (16)
30–35 13% (4) 33% (9) 28% (12)
36–40 3% (1) 37% (10) 21% (9)
Race/Ethnicity
Caucasian, non-Hispanic 41% (13) 51% (14) 53% (23)
African American, non-Hispanic 19% (6) 29% (8) 23% (10)
Other, non-Hispanic 0% (0) 0% (0) 2% (1)
Native American 13% (4) 3% (1) 0% (0)
Hispanic or Latina 28% (9) 15% (4) 21% (9)
Education
Less than HS 19% (6) 15% (0) 0% (0)
HS or equivalent 53% (17) 15% (5) 28% (12)
Some college 28% (9) 59% (16) 54% (23)
College graduate 0% (0) 22% (6) 19% (8)
a Other tobacco products used included electronic cigarettes, snus, chewing tobacco
and hookah.advertising, use by family members or friends, past experimentation,
or current use.
3.2.1.2. Product appeal.While most women expressed that snus was un-
attractive and unappealing, referring to it as “nasty” or “gross,” a few
found it intriguing or noted that the lack of an odor would be an advan-
tage over smoking. Women were divided on whether snus delivers
more or less nicotine than smoking.
“So this [snus] wouldn't appeal to me. Just - I don't want that in my
mouth.” (Pregnant quitter).
“And it's not nasty, because it's all contained in a sweet little pouch.
It's not like you got dip leaves coming up and - it'smore appealing to the
ladies. If you dip with this, in the little pouch that you can just toss
out…” (non-pregnant smoker).
Reactions to dissolvable products were also mixed. Women de-
scribed them as “weird,” “cool,” and “like a mint,” or uninteresting/me-
dicinal-looking. Many noted that these products would probably be
most often used by smokers in places where smoking was not allowed.
Some were concerned about high nicotine content in these products.
“Imight be interested in using it. Only for the fact because I think you
can be more discreet with it, and … I think it's convenient.” (pregnant
quitter).
“I think it would also be too much nicotine all at once.” (pregnant
smoker).
Participants were generally positive about the appearance of ENDS
products, calling them “cute,” “cool,” or “like a new toy.” Participants re-
ported trying ENDS for reasons such as the cheaper price, no ash or un-
pleasant odors, use in smoke-free areas, appealing ﬂavors, or to help
with smoking cessation. Others reported desirable similarities between
ENDS and traditional cigarettes, including comparable hand-to-mouth
motions, and being able see the exhaled “vapor.” Some noted that
ENDS are less harmful than regular cigarettes, and a few reported that
they could use ENDS around their children instead of smoking.
“…the ﬂavor kinds…I would almost rather do that than smoke a cig-
arette. It tastes so good…” (pregnant smoker).
“I think the idea behind it—is that because it's water vapor you're not
getting some of the tar and some of the other things you get out of a reg-
ular cigarette.” (pregnant smoker).
“…you feel a little safer, being in the car maybe with your kids.”
(pregnant quitter).
A few women who tried using ENDS to quit smoking reported be-
coming dual users. Others worried that they used their ENDS
excessively.
“What threw me off with them [electronic cigarettes] was that
there's no end point. Like if I'm smoking a regular cigarette, I know I
got ﬁve and a half, 6minutes, then I'm out. But I could smoke [electronic
cigarettes] all day long, and next thing I know, I been outside 30minutes
and I'm like oh God, I got to go back to work or whatever.” (non-preg-
nant smoker).
Women generally had negative views toward NRT. Many felt the
products were not effective because they or someone they knew had
tried them and had not been able to quit, and many complained about
the bad taste or side effects, such as bad dreams, nausea, or rashes.
Others commented that the products appear medicinal, are boring,
taste bad, can deliver toomuch nicotine or can be addictive themselves,
or do not replace aspects of smoking other than nicotine.
“I would not try those. I would rather quit cold turkey and be abso-
lutely bat-___ crazy…than to trade one chemical for another chemical.”
(non-pregnant smoker).
“If they want to make quitting smoking more exciting they need to
make something that actually tastes good or something.” (non-preg-
nant smoker).
“The patch can give you a nicotine overdose, so it's scary, smoking
and wearing it.” (pregnant smoker).
A few women who had not tried NRT in the past said they were in-
terested in trying it in the future to quit smoking. Regardless of their
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people to stop smoking, and not to use concurrently with smoking.
3.2.2. During pregnancy
Some participants noted that snus and dissolvables could be used
discreetly, thus, allowing women to avoid stigma from smoking while
pregnant.
“Maybe youwouldn't get judged by people because you could hide it
better than smoking. I don't like being judged by people, I hate that.”
(pregnant smoker).
Some women described an intention to use ENDS as a cessation aid
so they could quit before becoming pregnant while others suggested
that they might use them during pregnancy if they were not able to
quit on their own.
“This [electonic cigarettes] would be my step down…I want to
be smoke-free when I'm pregnant, so it's like if I need to be serious
about quitting smoking then that might be my option to be able to do
that before I get pregnant or I ﬁnd out I'm pregnant.” (non-pregnant
smoker).
Most women did not like the idea of taking unnecessary medicines
during pregnancy and felt it would be better to quit cold turkey than
to use NRT.
“I don't want any type of medicine intake in my body when I'm
pregnant… Any type of medicines.” (non-pregnant smoker).
3.2.3. Health risks associated with smoking, non-combusted tobacco
products, and NRT
3.2.3.1. General, not speciﬁc to pregnancy. Women attributed different
health risks to different types of tobacco products, but most thought
all products have at least some risks.Manywomen felt the health effects
of snus are similar to those of smoking cigarettes, such as causing can-
cer. Some thought snus and/or dissolvables might be more harmful
than cigarettes.
“I kind of equate it [dissolvables] with being similar to chewing to-
bacco, like you're putting it in your mouth…when they do that, you're
so much more at risk for - tongue and mouth and gum cancer. Esopha-
geal cancer, because if you're swallowing it, if you're sucking on it, that
would be breaking down your throat.” (pregnant quitter).
Women's responses were divided regarding the health effects of
ENDS. Some were concerned that because ENDS are new, there is not
much known about safety, while others believed them to be less harm-
ful than cigarettes.
“Scary, because there's no research on those, those vapor things.”
(pregnant quitter).
“I'd rather be addicted to nicotine without having to take in the car-
cinogens and tar, because nicotine is a stimulant like coffee, but it's not
like the carcinogen and tar kind of stuff, you're not getting.” (non-preg-
nant smoker).
Womenwere also divided on their perceptions of the health risks of
NRT, and many expressed concern about the amount of nicotine
delivered.
“Bowel problems because, you know, the lozenges, it's going in and
maybe it'll cause bowel cancer, or whatever you call that, colon cancer.”
(pregnant smoker).
“You could easily maybe overdose on those...” (pregnant smoker).
3.2.4. During pregnancy
Participants consistently reported that tobacco and products with
nicotine are harmful during pregnancy. Responses regarding which
products are most harmful varied, some felt all were equally dangerous
and some singled out a particular product as being relatively more or
less dangerous. Some pregnant smokers who were not already using
ENDSwere considering trying to switch, but otherswanted to quitwith-
out the assistance of other products.“…anything that's in your blood system goes to that baby, caffeine,
nicotine, all of it.” (non-pregnant smoker).
“You already take enough pills andmedicine to try to keep your baby
happy and this [NRT] seems like it would work against it. I think it's just
delivering too…it's too much and if it's getting in you it's deﬁnitely get-
ting in the baby.” (pregnant quitter).
Many women felt that using snus and dissolvables were especially
dangerous for pregnant women because the product is used orally and
saliva is swallowed.
“It's kind of like feeding it [dissolvables] to your baby directly. You're
feeding it cigarettes. It's crazy.” (pregnant smoker).
“And the cigarettes, you don't really know exactly where it's going.
But when you swallow that [dissolvables], you know it's going to go to
the baby.” (pregnant smoker).
Many pregnant quitters reported that they were committed to re-
maining tobacco free during pregnancy andwere not enticed by any to-
bacco products or NRT. However, some women expressed an intention
to try a different product after delivery.
“I know that I'll probably try the vapor [after the baby is born], the
blu, the e-cig or–I know I'll try those because I'm curious.” (pregnant
quitter).
Although many women were skeptical about using any nicotine-
containing products during pregnancy, some viewed individual prod-
ucts as potentially less harmful than the others. Women most often
mentioned ENDS as being least harmful, but a few singled out NRT or
dissolvables.
“… I feel like if I had a desperate moment during pregnancy I
wouldn't worry so much about the e-cigarette the way I would about
the tobacco.” (non-pregnant smoker).
4. Discussion
In this study of women's perceptions toward emerging non-
combusted tobacco products and NTR, women were generally unfamil-
iar with snus and dissolvable products, but did note some potential ad-
vantages of these products, such as use in smoke-free areas and the ease
of hiding these products from others. These ﬁndings raise concerns that
pregnant smokerswho feel stigmatizedmay be particularly attracted to
products that can be used discreetly. Interestingly, some women per-
ceived that inhaled tobacco from cigarette smoking is safer than oral to-
bacco, believing that oral use results in more direct exposure of the
fetus. Participants had greater familiarity with ENDS and NRT, and a
substantial number had used or were using ENDS. Of those who had
used ENDS, a few had intended to quit smoking, but became dual
users instead. Some women also expressed concern that ENDS are
easy to “overuse.” Because many women reduce the number of ciga-
rettes smoked per day when they become pregnant (Tong et al.,
2008), it is possible that some women could increase their nicotine ex-
posure through dual use or increased use of ENDS, especially if they per-
ceive ENDS to be less harmful than smoking. This could have important
implications for maternal and fetal health. In addition, although many
women who had quit smoking expressed strong intentions to avoid
all tobacco and nicotine-containing products during pregnancy, a few
did verbalize interest in using ENDS after delivery.
As previously stated, the American College of Obstetrics and Gyne-
cologists recommends NRT for consideration in pregnant smokers if be-
havioral therapy fails, after consideration of the potential risks and
beneﬁts (American College of Obstetricians and Gynecologists, 2011).
In our study, while NRT products were seen as “legitimate” products
speciﬁcally designed for smoking cessation rather than for use concur-
rently with smoking, many women felt NRT products were ineffective
and/or had unacceptable side effects. Many women viewed all NRT
and tobacco products as hazardous during pregnancy and expressed a
preference to quit without assistance from other tobacco or medicinal
products. However, some women viewed non-combusted products,
particularly ENDS, as less hazardous than smoking. This ﬁnding is
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pregnant women who had tried electronic cigarettes did so in order to
reduce harm. Regulating health and therapeutic claims while intensify-
ing efforts to educatewomen of the risks of these products could reduce
misperceptions about product safety among women of reproductive
age.
The current study has a number of limitations. Qualitative studies
such as this one are not generalizable to entire populations because of
their small sample size and limited geographic distribution of partici-
pants. Second, perceptions regarding non-combusted products likely
are changing rapidly in response to evolving advertising and marketing
strategies by tobacco companies as well as state and local tobacco poli-
cies. Our results reﬂect knowledge and perceptions for the fall of 2013 in
the selected cities. Third, our study design and limited sample size pre-
cluded comparisons of subgroups, such as those based on age, race/eth-
nicity, or education.
The 2011 College Committee Opinion on tobacco use instructs pro-
viders to screen for tobacco use in any form, including smokeless tobac-
co and electronic cigarettes (American College of Obstetricians and
Gynecologists, 2011). However, the Opinion does not include speciﬁc
information about the risks of these products. Our ﬁndings could be
used to inform efforts to better educate pregnant women about the
risks of nicotine and tobacco exposure during pregnancy. For example,
we found that some women were misinformed about how the route
of nicotine exposure affects fetal health, believing that oral tobacco or
oral NRT reaches the fetus more directly than inhaled tobacco. Future
research could generate additional information to guide the develop-
ment of educational materials for pregnant women addressing this
issue.
Our ﬁndings could also be used to inform future research related to
women's behaviors and exposure to tobacco and NRT. Future work
could investigate whether a desire to decrease the stigma associated
with smoking during pregnancy inﬂuences women to actually use
non-combusted tobacco products, and if so, to what extent; whether
pregnant women's positive attitudes toward ENDS and their negative
attitudes toward NRT make them more likely to use ENDS over NRT
when attempting to quit; to what extent pregnant smokers who try
ENDS become dual users; whether the use of ENDS in pregnant
women increases or decreases fetal nicotine exposure; and to what ex-
tent ENDS contribute to postpartum relapse amongquitters. In addition,
surveillance of use of emerging tobacco products among women of re-
productive age andpregnant and postpartumwomen is needed tomon-
itor trends in product use.
5. Conclusions
Women seeking to reduce health risks or stigma related to cigarette
use during pregnancymay perceive advantages to using some emerging
non-combusted products over cigarettes. These ﬁndings can inform fu-
ture research related to tobacco and NRT use among women of repro-
ductive age.
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